fDi Markets Newswire:

Tianjin siezes the tech initiative

Tianjin seizes the tech initiative

The Chinese city of Tianjin may lie in the shadow of investment behemoths Beijing and Shanghai, but it is still at the forefront of the country’s high-tech focus, with the Tianjin Economic-Technological Development Area central to its strong FDI appeal.

Spreading the wealth

Buffalo and Rochester look to up share of New York state spoils

Investment into the state of New York is naturally dominated by New York City, leaving the likes of Buffalo and Rochester trailing in its wake. However, after years of decline, the two cities look to be on the cusp of a revival, thanks in no small part to the state governor's ambitious investment plans.

EU policy threat to clinical trials

Experts are warning that EU policy on clinical trials in Europe could hamper innovation and investment, and stifle growth. 

US biotech

US states step-up to join biotech elite

The US biotechnology landscape has changed radically in the 20 years since the first BIO International Convention. And while investment is still focused on a handful of states, other US destinations are bubbling under.

New markets for life sciences sector

New markets for life sciences sector

While the US continues to take the lion’s share of investment and projects in the biotech and pharmaceutical sectors, locations in Asia and Europe are increasingly attracting the attention of investors. 

Dubai special economic zones

Dubai's free zones: something for everyone

Dubai’s free zones are drawing in businesses unfamiliar with the Middle East, thanks to a combination of an impressive infrastructure, sound business advice being on offer and low taxation. 

Ontario and Quebec up their biotech games

The leading two provinces for life sciences in Canada are not resting on their laurels when it comes to attracting investment, and both are now going all out to promote just how business-friendly their respective biotech clusters are.

UK top European destination for pharmaceutical investments in 2012

Six pharmaceutical FDI projects have been recorded in the UK in the  first quarter of 2012, making it the most popular destination in Europe  for such investments.

Julia Santos

Johnson & Johnson takes outsourcing route to business growth

Julia Santos, head of global business optimisation for the Johnson & Johnson Group, explains to Barbara Njau why outsourcing is essential to the company’s business strategy.

Belarus biotech TEASER

Belarus grasps pharmaceutical initiative

The pharmaceutical market in Belarus is seen as one of the country's most promising areas for economic growth, and with two pharma producers among its most profitable state-owned enterprises, this is a fact not lost on foreign investors.

fDi Tools

fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role: 

fdimarkets

For real-time crossborder greenfield investment data on all sectors and locations, click here

fdibenchmark

To benchmark locations for investment projects, click here

fdireports

For bespoke reports on companies, locations or sectors, click here